We read with great interest the recent review on etiology, diagnosis and management in aortic dissection. 1 In their discussion on diagnostic strategies, the authors state that useful biomarkers for aortic dissection are currently absent.
Response
Thomas Weber et al 1 are to be congratulated for their interest in serological screening, or the biomarker approach to the diagnosis of acute aortic syndrome.
Elevated serum D-dimers, however, are found as a reflection of endogenous fibrinolytic activity naturally counteracting the activation of the extrinsic pathway of the coagulation cascade; the latter is triggered by exposure to tissue factor from the dissected aorta (in other words, the formation of clot in the false lumen or any clot). Thus, D-dimers are specific for fibrinolytic activity triggered by thrombus formation as in coronary disease, pulmonary embolism, deep venous thrombosis, or acute dissection. [1] [2] [3] Not only is specificity low, but sensitivity also is a problem, because thresholds or cutoffs are not defined yet. Moreover, similar to other biomarkers for dissection, such as smooth muscle myosin heavy chains, or soluble elastin, a bedside test is not available, and subacute dissection will be missed as a result of short biological halflife 4 ; conversely, dissection in the evolving phase of intramural hematoma is unlikely to spill biomarkers into the circulation. 5 Thomas Weber, Johann Auer and Bernd Eber
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